Wall Street Analysts See a 56.65% Upside in Catalyst (CPRX): Can the Stock Really Move This High?

Catalyst Pharmaceutical (CPRX) closed the last trading session at $19.24, gaining 13.9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $30.14 indicates a 56.7% upside potential. The average comprises seven short-term price targets ranging from a low of $26 to a high of $38, with a standard deviation of $3.89. While the lowest estimate indicates an increase of 35.1% from the curren ...